StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) income statement

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.44−0.03 (-2.34%)

Close on Nov 20, 2026Market cap $1.88MP/E –Yield –

See a number that looks wrong?